The effect of omega 3 polyunsaturated fatty acids in serum CK-MB and troponin I as markers of myocardial injury after PCI
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20180217Keywords:
CK-MB, Troponin I, PCI, Omega 3Abstract
Background: The mortality rate of patients with this disease is approximately 30%. Re-opening of blocked coronary artery is important because of decreasing mortality and improves quality of life in patients with acute myocardial infarction. Now there are various methods for opening coronary artery, including the use of thrombolytic drugs and PCI. Due to the fact that PCI is a critical treatment for cardiovascular patients yet it has dangerous complications during and after it too. Some of these complications include vascular dissection, and thrombosis and ischemic sudden blockage. By reducing the side effects of this treatment, it can be safe and reliable construction. To determine the effect of Omega 3 in the prevention of myocardial injury induced by coronary interventional procedures by reducing levels of CK-MB and Troponin I is our objective.
Methods: Among those who were randomly going for elective PCI, we selected 100 patients and divided into 2 groups of 50 persons. In Group A, 12 hours before PCI, approximately 3 grams of omega-3, with routine medications before PCI include Aspirin and Plavix were given. In Group B, 12 hours before PCI placebo in combination with routine medication before were given and PCI was performed, then the CK-MB and Troponin I in the 2 groups was measured and compared to each other and against the values before performing PCI were measured.
Results: The results that were obtained, show that levels of CK-MB and Troponin I raise after PCI in Group A lower than Group B.
Conclusions: Results confirmed the effect of omega 3 in the prevention of myocardial damage caused by PCI, so we can use omega 3 for reducing PCI complications.
References
Safdari R, Ghazi Saeedi M, Gharooni M, Nasiri M, Arji G. Comparing performance of decision tree and neural network in predicting myocardial infarction. JPSR. 2014;3(2):26-35.
Karimy T, Saffari M, Sanaeinasab H, Khalagi K, Hassan-Abadi M. The impact of educational intervention based on the theory of planned behavior on lifestyle change of patients with myocardial infarction. Iran J Health Educ Health Promot. 2016;3(4):370- 80.
Loyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121(7):948-54.
Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503-16.
Teo KK, Sedlis SP, Boden WE, O'Rourke RA, Maron DJ, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial. J Am Coll Cardiol. 2009;54(14):1303-8.
Prasad A, Gersh BJ, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, Et al. Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol. 2009;54(5):477-86.
Bhatt DL, Topol EJ. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes. Circulation. 2005;112(6):906-15; discussion 923.
Smith WS, Johnston SC, Easton JD. Cerebrovascular diseases. In: Kasper DL, Braunwald E, Fauci AS, Hauser S, Longo D, Jameson JL, editors. Harrison's principles of internal medicine. 16th ed. New York: McGraw-Hill; 2005.
Valent F, Wayne A, Robert OR, Hurst S. The heart.10th ed. NewYork, McGraw– Hill. 2001: 201-230.
